Abstract
Regioselective synthesis of spiro [indole -3(3H), 2 (3H)perimidine]2(1H)one (4a-e) for potential application in cancer treatment under conventionally and microwave irradiation using different solvents/solid support has been studied. A judicious choice of the reaction conditions allowed the titled product 4a-e to be generated in excellent yields.
Keywords: Perimidine, indole 2,3-dione, microwave, 1,8-diaminonapthalene, montmorillonite KSF, cytotoxic
Letters in Organic Chemistry
Title: Regioselective Synthesis of Biologically Important Scaffold Spiro [Indole- Perimidines]: An Antitumor Agents
Volume: 4 Issue: 5
Author(s): Kapil Arya and Anshu Dandia
Affiliation:
Keywords: Perimidine, indole 2,3-dione, microwave, 1,8-diaminonapthalene, montmorillonite KSF, cytotoxic
Abstract: Regioselective synthesis of spiro [indole -3(3H), 2 (3H)perimidine]2(1H)one (4a-e) for potential application in cancer treatment under conventionally and microwave irradiation using different solvents/solid support has been studied. A judicious choice of the reaction conditions allowed the titled product 4a-e to be generated in excellent yields.
Export Options
About this article
Cite this article as:
Kapil Arya and Anshu Dandia , Regioselective Synthesis of Biologically Important Scaffold Spiro [Indole- Perimidines]: An Antitumor Agents, Letters in Organic Chemistry 2007; 4 (5) . https://dx.doi.org/10.2174/157017807781212175
DOI https://dx.doi.org/10.2174/157017807781212175 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell and Gene-Based Therapies for the Lysosomal Storage Diseases
Current Gene Therapy Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Hsp90 Flexibility and Development of its Inhibitors for the Treatment of Cancer
Current Chemical Biology Solvent-free Synthesis and Antimicrobial Properties of Some Novel Furanone and Spiropyrimidone Derivatives
Current Organic Synthesis Synthesis and Anticancer Activity of 2-Aryl-6-diethylaminoquinazolinone Derivatives
Letters in Drug Design & Discovery Roles of miRNA in the Initiation and Development of Colorectal Carcinoma
Current Pharmaceutical Design Anticancer Agents Derived from Natural Products
Mini-Reviews in Medicinal Chemistry Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Modulation of the Ceramide Level, A Novel Therapeutic Concept
Current Drug Targets Cancer and Treatment Modalities
Current Cancer Therapy Reviews Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection
MicroRNA Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Phytochemical and Biological Activities of an Anticancer Plant Medicine: Brucea javanica
Anti-Cancer Agents in Medicinal Chemistry Thyroid Function and Obesity: From Mechanisms to the Benefits of Levothyroxine in Obese Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Bid Stands at the Crossroad of Stress-Response Pathways
Current Cancer Drug Targets L1 Retrotransposon and Retinoblastoma: Molecular Linkages Between Epigenetics and Cancer
Current Molecular Medicine Computational Docking Studies of Novel Heterocyclic Carboxamides as Potential PI3Kα Inhibitors
Letters in Drug Design & Discovery Schiff Bases and their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works
Anti-Cancer Agents in Medicinal Chemistry Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics
Current Cancer Drug Targets